EDGAR Filing Documents for 0001737287-21-000014

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001737287-21-000014

Filing Date

2021-04-22

Accepted

2021-04-22 16:29:27

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	allo-20210423xdefa14axprox.htm	DEFA14A	21781
2		allogenetherapeuticsinc_pr.jpg	GRAPHIC	289914
3		allogenetherapeuticsinc_pra.jpg	GRAPHIC	344878
	Complete submission text file	0001737287-21-000014.txt		897357

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080

Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700

Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38693 | Film No.: 21845177
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences